These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35779262)

  • 1. RNA interference protocol to silence oncogenic drivers in leukemia cell lines.
    Beyer M; Krämer OH
    STAR Protoc; 2022 Sep; 3(3):101512. PubMed ID: 35779262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfection of siRNAs in multiple myeloma cell lines.
    Brito JL; Brown N; Morgan GJ
    Methods Mol Biol; 2010; 623():299-309. PubMed ID: 20217559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated 96-well format high throughput colony formation assay for siRNA library screen.
    Hatch SB; Prevo R; Chan T; Millar V; Cornelissen B; Higgins G; Ebner D
    STAR Protoc; 2022 Jun; 3(2):101355. PubMed ID: 35542177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference as a potential tool in the treatment of leukaemia.
    Borkhardt A; Heidenreich O
    Expert Opin Biol Ther; 2004 Dec; 4(12):1921-9. PubMed ID: 15571454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi in cultured mammalian cells using synthetic siRNAs.
    Chang K; Marran K; Valentine A; Hannon GJ
    Cold Spring Harb Protoc; 2012 Sep; 2012(9):957-61. PubMed ID: 22949722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi Screening of Leukemia Cells Using Electroporation.
    Agarwal A; Tyner JW
    Methods Mol Biol; 2016; 1470():85-94. PubMed ID: 27581286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA.
    Saayman S; Barichievy S; Capovilla A; Morris KV; Arbuthnot P; Weinberg MS
    PLoS One; 2008 Jul; 3(7):e2602. PubMed ID: 18596982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of FMS-like tyrosine kinase 3 targeted RNA interference on proliferation and apoptosis of acute monocytic leukemia cell line THP-1].
    Lu J; Sheng GY; Zou X; Xu XJ; Zhao XM; Bai ST; Xu PR
    Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):615-9. PubMed ID: 18021537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms).
    Donner L; Fedele LA; Garon CF; Anderson SJ; Sherr CJ
    J Virol; 1982 Feb; 41(2):489-500. PubMed ID: 6281462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two hit hypothesis: an improved method for siRNA-mediated gene silencing in stimulated primary human T cells.
    Freeley M; Long A
    J Immunol Methods; 2013 Oct; 396(1-2):116-27. PubMed ID: 23988722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Silencing of lncRNA Expression Using siRNAs.
    Thijssen MS; Bintz J; Arnes L
    Methods Mol Biol; 2021; 2348():141-156. PubMed ID: 34160804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative imaging of single-cell phenotypes in cancer cells cultured on hydrogel surfaces.
    Bousgouni V; Bakal C
    STAR Protoc; 2023 Mar; 4(1):101942. PubMed ID: 36525347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells.
    Brito JL; Davies FE; Gonzalez D; Morgan GJ
    J Immunol Methods; 2008 Apr; 333(1-2):147-55. PubMed ID: 18299137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro application of RNA interference to silence livin gene expression to induce apoptosis in leukemia cells.
    Lv J; Qin ZP; Zheng MF; Chen ZC; Wang Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4390-6. PubMed ID: 26636528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of field isolates of feline calicivirus with short interfering RNAs (siRNAs).
    McDonagh P; Sheehy PA; Fawcett A; Norris JM
    Vet Microbiol; 2015 May; 177(1-2):78-86. PubMed ID: 25770890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells.
    Ghildiyal M; Seitz H; Horwich MD; Li C; Du T; Lee S; Xu J; Kittler EL; Zapp ML; Weng Z; Zamore PD
    Science; 2008 May; 320(5879):1077-81. PubMed ID: 18403677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo.
    Chaudhuri L; Vincelette ND; Koh BD; Naylor RM; Flatten KS; Peterson KL; McNally A; Gojo I; Karp JE; Mesa RA; Sproat LO; Bogenberger JM; Kaufmann SH; Tibes R
    Haematologica; 2014 Apr; 99(4):688-96. PubMed ID: 24179152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a transformation-defective mutant of the McDonough strain of feline sarcoma virus exhibiting tyrosine kinase activity in vitro but not in vivo.
    Tamura T; Hennig D; Grell M; Niemann H; Boschek B
    J Virol; 1988 Jun; 62(6):2150-7. PubMed ID: 2835515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
    Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
    Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.